Literature DB >> 33420223

FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs.

Billie G C Griffith1, Rosanna Upstill-Goddard2, Holly Brunton2,3, Graeme R Grimes4, Andrew V Biankin2, Bryan Serrels5,6, Adam Byron7, Margaret C Frame8.   

Abstract

Focal adhesion kinase (FAK) localizes to focal adhesions and is overexpressed in many cancers. FAK can also translocate to the nucleus, where it binds to, and regulates, several transcription factors, including MBD2, p53 and IL-33, to control gene expression by unknown mechanisms. We have used ATAC-seq to reveal that FAK controls chromatin accessibility at a subset of regulated genes. Integration of ATAC-seq and RNA-seq data showed that FAK-dependent chromatin accessibility is linked to differential gene expression, including of the FAK-regulated cytokine and transcriptional regulator interleukin-33 (Il33), which controls anti-tumor immunity. Analysis of the accessibility peaks on the Il33 gene promoter/enhancer regions revealed sequences for several transcription factors, including ETS and AP-1 motifs, and we show that c-Jun, a component of AP-1, regulates Il33 gene expression by binding to its enhancer in a FAK kinase-dependent manner. This work provides the first demonstration that FAK controls transcription via chromatin accessibility, identifying a novel mechanism by which nuclear FAK regulates biologically important gene expression.

Entities:  

Year:  2021        PMID: 33420223      PMCID: PMC7794255          DOI: 10.1038/s41598-020-80111-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  56 in total

Review 1.  Transcriptional regulatory elements in the human genome.

Authors:  Glenn A Maston; Sara K Evans; Michael R Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

Review 2.  Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.

Authors:  Binfeng Lu; Min Yang; Qingqing Wang
Journal:  J Mol Med (Berl)       Date:  2016-02-27       Impact factor: 4.599

3.  Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.

Authors:  Katrin Palumbo-Zerr; Pawel Zerr; Alfiya Distler; Judith Fliehr; Rossella Mancuso; Jingang Huang; Dirk Mielenz; Michal Tomcik; Barbara G Fürnrohr; Carina Scholtysek; Clara Dees; Christian Beyer; Gerhard Krönke; Daniel Metzger; Oliver Distler; Georg Schett; Jörg H W Distler
Journal:  Nat Med       Date:  2015-01-12       Impact factor: 53.440

4.  AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection.

Authors:  Thomas Vierbuchen; Emi Ling; Christopher J Cowley; Cameron H Couch; Xiaofeng Wang; David A Harmin; Charles W M Roberts; Michael E Greenberg
Journal:  Mol Cell       Date:  2017-12-21       Impact factor: 17.970

5.  Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.

Authors:  Sang-Gu Hwang; Sung-Sook Yu; Soo-Woong Lee; Jang-Soo Chun
Journal:  FEBS Lett       Date:  2005-08-29       Impact factor: 4.124

6.  Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway.

Authors:  Ryu-Suke Nozawa; Koji Nagao; Ken-Taro Igami; Sachiko Shibata; Natsuko Shirai; Naohito Nozaki; Takashi Sado; Hiroshi Kimura; Chikashi Obuse
Journal:  Nat Struct Mol Biol       Date:  2013-03-31       Impact factor: 15.369

7.  Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase.

Authors:  B K Chen; W C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 8.  Targeting inflammation by modulating the Jun/AP-1 pathway.

Authors:  Helia B Schonthaler; Juan Guinea-Viniegra; Erwin F Wagner
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

9.  Nuclear transport of paxillin depends on focal adhesion dynamics and FAT domains.

Authors:  Aneesh R Sathe; G V Shivashankar; Michael P Sheetz
Journal:  J Cell Sci       Date:  2016-04-11       Impact factor: 5.285

10.  HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.

Authors:  Holly Brunton; Giuseppina Caligiuri; Richard Cunningham; Rosie Upstill-Goddard; Ulla-Maja Bailey; Ian M Garner; Craig Nourse; Stephan Dreyer; Marc Jones; Kim Moran-Jones; Derek W Wright; Viola Paulus-Hock; Colin Nixon; Gemma Thomson; Nigel B Jamieson; Grant A McGregor; Lisa Evers; Colin J McKay; Aditi Gulati; Rachel Brough; Ilirjana Bajrami; Stephen J Pettitt; Michele L Dziubinski; Simon T Barry; Robert Grützmann; Robert Brown; Edward Curry; Marina Pajic; Elizabeth A Musgrove; Gloria M Petersen; Emma Shanks; Alan Ashworth; Howard C Crawford; Diane M Simeone; Fieke E M Froeling; Christopher J Lord; Debabrata Mukhopadhyay; Christian Pilarsky; Sean E Grimmond; Jennifer P Morton; Owen J Sansom; David K Chang; Peter J Bailey; Andrew V Biankin
Journal:  Cell Rep       Date:  2020-05-12       Impact factor: 9.995

View more
  3 in total

1.  Characterisation of a nucleo-adhesome.

Authors:  Billie G C Griffith; Ana Herrero; Adam Byron; Alexander E P Loftus; Emma S Koeleman; Linda Kogerman; John C Dawson; Niamh McGivern; Jayne Culley; Graeme R Grimes; Bryan Serrels; Alex von Kriegsheim; Valerie G Brunton; Margaret C Frame
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

Review 2.  New Insights on the Nuclear Functions and Targeting of FAK in Cancer.

Authors:  Silvia Pomella; Matteo Cassandri; Maria Rita Braghini; Francesco Marampon; Anna Alisi; Rossella Rota
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

Review 3.  FAK in Cancer: From Mechanisms to Therapeutic Strategies.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Michael Hsiao; Ming-Shyan Huang; Chih-Jen Yang
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.